Psilocybin: A brief overview for psychiatric mental health nurse practitioners
Dina Fradkin
Perspectives In Psychiatric Care June 8, 2021 DOI: 10.1111/ppc.12888 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Anxiety Psilocybin |
| Keywords | Hallucinogen Modalities Mental health care Depression economics Psychotherapist Nursing |
| Citations | 3 |
| Key findings | Psilocybin shows relative safety and potential efficacy for treating psychiatric disorders, and psychiatric mental health nurse practitioners must understand its principles to deliver care. |
Abstract
The use of psychedelics, such as psilocybin, has emerged in recent literature as a novel therapeutic treatment for various psychiatric disorders, including substance use, depression, and anxiety. While international and domestic trials are currently underway, there is data demonstrating both the relative safety and potential efficacy of psilocybin. Psychiatric mental health nurse practitioners are essential mental health providers that may be at the forefront of delivering these new treatment modalities. Therefore, they must be aware of the psychopharmacological and psychotherapeutic tenets of psilocybin to be prepared to treat patients.
Comparable studies
Other narrative reviews on psilocybin for anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelics as anti-inflammatory agents Animal models and cellular studies | 2018 | Review | |
| Ayahuasca: Pharmacology, neuroscience and therapeutic potential | 2016 | Review | |
| Psychedelic Drugs in Biomedicine | 2017 | Review | |
| A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses | 2020 | Review | |
| Psychedelics and health behaviour change | 2021 | Review |
Citations in the library
Cited by 3
- Predictors of Medical Students' Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice. Cureus April 1, 2023
- Psilocybe cubensis: potencial neuropsicofarmacéutico de la psilocibina y psilocina Tecnología en Marcha May 20, 2025
- Is Therapeutic Use of Psychedelic Medication Influenced by Bias? Journal of the American Psychiatric Nurses Association August 10, 2023
Cites 17
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Long-term follow-up of psilocybin-facilitated smoking cessation The American Journal of Drug and Alcohol Abuse July 21, 2016
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
and 12 more in the library